{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:25:29Z","timestamp":1787034329267,"version":"build-2736575974"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2022YFS0212"],"award-info":[{"award-number":["2022YFS0212"]}]},{"name":"Emerging Tumor Translational Medicine Program of the China Health and Medical Development Foundation","award":["chmdf2025-xrky01-04"],"award-info":[{"award-number":["chmdf2025-xrky01-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-026-10419-9","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:38:17Z","timestamp":1787031497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["THBS2: the key hub linking breast cancer stroma, immunity, and therapeutic response"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9464-4672","authenticated-orcid":false,"given":"Xi","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"3","key":"10419_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10419_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","volume":"24","author":"L Luo","year":"2025","unstructured":"Luo L, Yang P, Mastoraki S et al (2025) Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer. Mol Cancer 24(1):48. https:\/\/doi.org\/10.1186\/s12943-025-02226-9","journal-title":"Mol Cancer"},{"issue":"1","key":"10419_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","volume":"23","author":"M Kundu","year":"2024","unstructured":"Kundu M, Butti R, Panda VK et al (2024) Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer 23(1):92. https:\/\/doi.org\/10.1186\/s12943-024-01990-4","journal-title":"Mol Cancer"},{"issue":"2","key":"10419_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00280-020-04222-w","volume":"87","author":"N Wang","year":"2021","unstructured":"Wang N, Liu W, Zheng Y et al (2021) Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemother Pharmacol 87(2):147\u2013158. https:\/\/doi.org\/10.1007\/s00280-020-04222-w","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"10419_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14728222.2022.2170779","volume":"26","author":"N Furukawa","year":"2022","unstructured":"Furukawa N, Stearns V, Santa-Maria CA, Popel AS (2022) The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert Opin Ther Targets 26(12):1041\u20131056. https:\/\/doi.org\/10.1080\/14728222.2022.2170779","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10419_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-021-06405-2","volume":"191","author":"A Hernando-Calvo","year":"2022","unstructured":"Hernando-Calvo A, Cescon DW, Bedard PL (2022) Novel classes of immunotherapy for breast cancer. Breast Cancer Res Treat 191(1):15\u201329. https:\/\/doi.org\/10.1007\/s10549-021-06405-2","journal-title":"Breast Cancer Res Treat"},{"key":"10419_CR7","doi-asserted-by":"publisher","first-page":"156051","DOI":"10.1016\/j.phymed.2024.156051","volume":"135","author":"C Li","year":"2024","unstructured":"Li C, Wang X, Xing L et al (2024) Huaier-induced suppression of cancer-associated fibroblasts confers immunotherapeutic sensitivity in triple-negative breast cancer. Phytomedicine 135:156051. https:\/\/doi.org\/10.1016\/j.phymed.2024.156051","journal-title":"Phytomedicine"},{"issue":"10","key":"10419_CR8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos P, Barbera-Mourelle A, Barreiro O et al (2022) Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell 185(10):1694\u20131708e19. https:\/\/doi.org\/10.1016\/j.cell.2022.03.033","journal-title":"Cell"},{"issue":"4","key":"10419_CR9","doi-asserted-by":"publisher","first-page":"M111014647","DOI":"10.1074\/mcp.M111.014647","volume":"11","author":"A Naba","year":"2012","unstructured":"Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteom MCP 11(4):M111014647. https:\/\/doi.org\/10.1074\/mcp.M111.014647","journal-title":"Mol Cell Proteom MCP"},{"key":"10419_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.matbio.2014.01.012","volume":"37","author":"A Resovi","year":"2014","unstructured":"Resovi A, Pinessi D, Chiorino G, Taraboletti G (2014) Current understanding of the thrombospondin-1 interactome. Matrix Biol J Int Soc Matrix Biol 37:83\u201391. https:\/\/doi.org\/10.1016\/j.matbio.2014.01.012","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"issue":"6","key":"10419_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol 12(6):325\u2013338. https:\/\/doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephrol"},{"issue":"139","key":"10419_CR12","first-page":"211","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu J, Shen JX, Wu HT et al (2018) Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med 25(139):211\u2013223","journal-title":"Discov Med"},{"issue":"2","key":"10419_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18(2):99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10419_CR14","doi-asserted-by":"publisher","first-page":"10133","DOI":"10.18632\/oncotarget.7100","volume":"7","author":"S Kaur","year":"2016","unstructured":"Kaur S, Elkahloun AG, Singh SP et al (2016) A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer. Oncotarget 7(9):10133\u201310152. https:\/\/doi.org\/10.18632\/oncotarget.7100","journal-title":"Oncotarget"},{"issue":"1","key":"10419_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/71517","volume":"6","author":"B Jim\u00e9nez","year":"2000","unstructured":"Jim\u00e9nez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6(1):41\u201348. https:\/\/doi.org\/10.1038\/71517","journal-title":"Nat Med"},{"key":"10419_CR16","doi-asserted-by":"publisher","first-page":"1610559","DOI":"10.3389\/pore.2022.1610559","volume":"28","author":"Y Lin","year":"2022","unstructured":"Lin Y, Lin E, Li Y et al (2022) Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy. Pathol Oncol Res POR 28:1610559. https:\/\/doi.org\/10.3389\/pore.2022.1610559","journal-title":"Pathol Oncol Res POR"},{"issue":"9","key":"10419_CR17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL et al (2021) A single-cell and spatially resolved atlas of human breast cancers. Nat Genet 53(9):1334\u20131347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1","journal-title":"Nat Genet"},{"issue":"1","key":"10419_CR18","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1038\/s41598-018-31126-w","volume":"8","author":"LA Tomko","year":"2018","unstructured":"Tomko LA, Hill RC, Barrett A et al (2018) Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma. Sci Rep 8(1):12941. https:\/\/doi.org\/10.1038\/s41598-018-31126-w","journal-title":"Sci Rep"},{"issue":"11","key":"10419_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.celrep.2015.11.025","volume":"13","author":"Y Del Pozo Martin","year":"2015","unstructured":"Del Pozo Martin Y, Park D, Ramachandran A et al (2015) Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization. Cell Rep 13(11):2456\u20132469. https:\/\/doi.org\/10.1016\/j.celrep.2015.11.025","journal-title":"Cell Rep"},{"issue":"7","key":"10419_CR20","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.62347\/UXWK4038","volume":"14","author":"Z Chang","year":"2024","unstructured":"Chang Z, Gao Y, Chen P et al (2024) THBS2 promotes gastric cancer progression and stemness via the Notch signaling pathway. Am J Cancer Res 14(7):3433\u20133450. https:\/\/doi.org\/10.62347\/UXWK4038","journal-title":"Am J Cancer Res"},{"key":"10419_CR21","doi-asserted-by":"publisher","first-page":"4405491","DOI":"10.1155\/2021\/4405491","volume":"2021","author":"C Zhang","year":"2021","unstructured":"Zhang C, Hu C, Su K et al (2021) The Integrative Analysis of Thrombospondin Family Genes in Pan-Cancer Reveals that THBS2 Facilitates Gastrointestinal Cancer Metastasis. J Oncol 2021:4405491. https:\/\/doi.org\/10.1155\/2021\/4405491","journal-title":"J Oncol"},{"issue":"1","key":"10419_CR22","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1038\/s41467-021-24215-4","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Chen S, Huang K et al (2021) Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nat Commun 12(1):3928. https:\/\/doi.org\/10.1038\/s41467-021-24215-4","journal-title":"Nat Commun"},{"key":"10419_CR23","doi-asserted-by":"publisher","first-page":"115455","DOI":"10.1016\/j.biopha.2023.115455","volume":"167","author":"J Huang","year":"2023","unstructured":"Huang J, Wang C, Hou Y et al (2023) Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K\/AKT\/mTOR signaling pathway. Biomed Pharmacother 167:115455. https:\/\/doi.org\/10.1016\/j.biopha.2023.115455","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10419_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0945-053X(00)00104-9","volume":"19","author":"P Bornstein","year":"2000","unstructured":"Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z (2000) Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19(7):557\u2013568. https:\/\/doi.org\/10.1016\/S0945-053X(00)00104-9","journal-title":"Matrix Biol"},{"key":"10419_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","volume":"528","author":"P Nan","year":"2022","unstructured":"Nan P, Dong X, Bai X et al (2022) Tumor-stroma TGF-\u03b21-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1v\u03b23\/CD36-mediated activation of the MAPK pathway. Cancer Lett 528:59\u201375. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.025","journal-title":"Cancer Lett"},{"issue":"5","key":"10419_CR26","doi-asserted-by":"publisher","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","volume":"2","author":"PR Lawler","year":"2012","unstructured":"Lawler PR, Lawler J (2012) Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and \u2013\u20092. Cold Spring Harb Perspect Med 2(5):a006627. https:\/\/doi.org\/10.1101\/cshperspect.a006627","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"10419_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.stem.2024.04.011","volume":"31","author":"T Guo","year":"2024","unstructured":"Guo T, Pei F, Zhang M et al (2024) Vascular architecture regulates mesenchymal stromal cell heterogeneity via P53-PDGF signaling in the mouse incisor. Cell Stem Cell 31(6):904\u2013920e6. https:\/\/doi.org\/10.1016\/j.stem.2024.04.011","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10419_CR28","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jhep.2021.07.016","volume":"75","author":"G Carpino","year":"2021","unstructured":"Carpino G, Cardinale V, Di Giamberardino A et al (2021) Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. J Hepatol 75(6):1377\u20131386. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.016","journal-title":"J Hepatol"},{"issue":"1","key":"10419_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"J Wang","year":"2024","unstructured":"Wang J, Li Y, Zhang X et al (2024) THBS2\u2009+\u2009cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Mol Cancer 23(1):119. https:\/\/doi.org\/10.1186\/s12943-024-02180-y","journal-title":"Mol Cancer"},{"key":"10419_CR30","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.csbj.2024.05.021","volume":"23","author":"J Li","year":"2024","unstructured":"Li J, Tang Y, Long F et al (2024) Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer. Comput Struct Biotechnol J 23:2251\u20132266. https:\/\/doi.org\/10.1016\/j.csbj.2024.05.021","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"10419_CR31","doi-asserted-by":"publisher","first-page":"e0141763","DOI":"10.1371\/journal.pone.0141763","volume":"10","author":"P Cossu-Rocca","year":"2015","unstructured":"Cossu-Rocca P, Orr\u00f9 S, Muroni MR et al (2015) Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer. PLoS ONE 10(11):e0141763. https:\/\/doi.org\/10.1371\/journal.pone.0141763","journal-title":"PLoS ONE"},{"key":"10419_CR32","doi-asserted-by":"publisher","unstructured":"Shu X, Zhan PP, Sun LX et al (2021) BCAT1 Activates PI3K\/AKT\/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.659260","DOI":"10.3389\/fcell.2021.659260"},{"key":"10419_CR33","doi-asserted-by":"publisher","unstructured":"L Q, B S, B Y, S L. CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation. Hum Mol Genet. (2023) ;32(11). https:\/\/doi.org\/10.1093\/hmg\/ddad022","DOI":"10.1093\/hmg\/ddad022"},{"issue":"12","key":"10419_CR34","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1074\/jbc.M803650200","volume":"284","author":"H Meng","year":"2009","unstructured":"Meng H, Zhang X, Hankenson KD, Wang MM (2009) Thrombospondin 2 Potentiates Notch3\/Jagged1 Signaling. J Biol Chem 284(12):7866\u20137874. https:\/\/doi.org\/10.1074\/jbc.M803650200","journal-title":"J Biol Chem"},{"key":"10419_CR35","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.neo.2024.101041","volume":"57","author":"K Yao","year":"2024","unstructured":"Yao K, Zhan XY, Feng M, Yang KF, Zhou MS, Jia H, Furin (2024) ADAM, and \u03b3-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer. Neoplasia N Y N 57:101041. https:\/\/doi.org\/10.1016\/j.neo.2024.101041","journal-title":"Neoplasia N Y N"},{"issue":"2","key":"10419_CR36","doi-asserted-by":"publisher","first-page":"e0117097","DOI":"10.1371\/journal.pone.0117097","volume":"10","author":"J Xu","year":"2015","unstructured":"Xu J, Prosperi JR, Choudhury N, Olopade OI, Goss KH (2015) \u03b2-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells. PLoS ONE 10(2):e0117097. https:\/\/doi.org\/10.1371\/journal.pone.0117097","journal-title":"PLoS ONE"},{"issue":"5","key":"10419_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/kjm2.12528","volume":"38","author":"HL Qu","year":"2022","unstructured":"Qu HL, Hasen GW, Hou YY, Zhang CX (2022) THBS2 promotes cell migration and invasion in colorectal cancer via modulating Wnt\/\u03b2-catenin signaling pathway. Kaohsiung J Med Sci 38(5):469\u2013478. https:\/\/doi.org\/10.1002\/kjm2.12528","journal-title":"Kaohsiung J Med Sci"},{"key":"10419_CR38","doi-asserted-by":"publisher","first-page":"138267","DOI":"10.1016\/j.ijbiomac.2024.138267","volume":"285","author":"J Wang","year":"2025","unstructured":"Wang J, Zhu R, Dong Y et al (2025) YTHDF3 suppresses declines in corneal epithelial wound healing through upregulating the Wnt\/\u03b2-catenin signaling pathway and THBS2 expression in diabetic corneas. Int J Biol Macromol 285:138267. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138267","journal-title":"Int J Biol Macromol"},{"key":"10419_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-024-03107-7","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu Y, Lv H, Liu X et al (2024) The RP11-417E7.1\/THBS2 signaling pathway promotes colorectal cancer metastasis by activating the Wnt\/\u03b2-catenin pathway and facilitating exosome-mediated M2 macrophage polarization. J Exp Clin Cancer Res 43:195. https:\/\/doi.org\/10.1186\/s13046-024-03107-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"10419_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00036.2023","volume":"104","author":"JFC Glatz","year":"2024","unstructured":"Glatz JFC, Heather LC, Luiken J (2024) CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiol Rev 104(2):727\u2013764. https:\/\/doi.org\/10.1152\/physrev.00036.2023","journal-title":"Physiol Rev"},{"issue":"17","key":"10419_CR41","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi A, Mukherjee A, Kenny HA et al (2018) Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37(17):2285\u20132301. https:\/\/doi.org\/10.1038\/s41388-017-0093-z","journal-title":"Oncogene"},{"issue":"7","key":"10419_CR42","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/stem.1716","volume":"32","author":"JS Hale","year":"2014","unstructured":"Hale JS, Otvos B, Sinyuk M et al (2014) Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells 32(7):1746\u20131758. https:\/\/doi.org\/10.1002\/stem.1716","journal-title":"Stem Cells"},{"issue":"72","key":"10419_CR43","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/scisignal.272re3","volume":"2","author":"RL Silverstein","year":"2009","unstructured":"Silverstein RL, Febbraio M (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2(72):re3. https:\/\/doi.org\/10.1126\/scisignal.272re3","journal-title":"Sci Signal"},{"issue":"1","key":"10419_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-019-1049-7","volume":"38","author":"J Pan","year":"2019","unstructured":"Pan J, Fan Z, Wang Z (2019) CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT\/GSK-3\u03b2\/\u03b2-catenin pathway. J Exp Clin Cancer Res 38(1):52. https:\/\/doi.org\/10.1186\/s13046-019-1049-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"7635","key":"10419_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S et al (2017) Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541(7635):41\u201345. https:\/\/doi.org\/10.1038\/nature20791","journal-title":"Nature"},{"issue":"44","key":"10419_CR46","doi-asserted-by":"publisher","first-page":"27412","DOI":"10.1073\/pnas.2002997117","volume":"117","author":"PB Yang","year":"2020","unstructured":"Yang PB, Hou PP, Liu FY et al (2020) Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc Natl Acad Sci USA 117(44):27412\u201327422. https:\/\/doi.org\/10.1073\/pnas.2002997117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10419_CR47","doi-asserted-by":"publisher","first-page":"e70493","DOI":"10.1002\/mco2.70493","volume":"6","author":"X Wu","year":"2025","unstructured":"Wu X, Wang Y, Peng Z et al (2025) CD36 inhibits triple-negative breast cancer progression by transcriptionally upregulating caveolin-1 and promoting lipid-reactive oxygen species-related ferroptosis. MedComm 6(12):e70493. https:\/\/doi.org\/10.1002\/mco2.70493","journal-title":"MedComm"},{"issue":"1","key":"10419_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C (2024) Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol 13(1):80. https:\/\/doi.org\/10.1186\/s40164-024-00543-1","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"10419_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-022-00363-1","volume":"12","author":"L Guo","year":"2023","unstructured":"Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W et al (2023) Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol 12(1):3. https:\/\/doi.org\/10.1186\/s40164-022-00363-1","journal-title":"Exp Hematol Oncol"},{"key":"10419_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s11864-023-01069-0","volume":"24","author":"V Geurts","year":"2023","unstructured":"Geurts V, Kok M (2023) Immunotherapy for metastatic triple-negative breast cancer: current paradigm and future approaches. Curr Treat Options Oncol 24:628\u2013643. https:\/\/doi.org\/10.1007\/s11864-023-01069-0","journal-title":"Curr Treat Options Oncol"},{"key":"10419_CR51","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1038\/s41467-021-25962-0","volume":"12","author":"D Hammerl","year":"2021","unstructured":"Hammerl D, Martens JWM, Timmermans M, Smid M, Trapman-Jansen AM, Foekens R et al (2021) Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple-negative breast cancer. Nat Commun 12:5668. https:\/\/doi.org\/10.1038\/s41467-021-25962-0","journal-title":"Nat Commun"},{"key":"10419_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13046-025-03211-6","volume":"44","author":"S Imani","year":"2025","unstructured":"Imani S, Farghadani R, Roozitalab G, Maghsoudloo M, Emadi M, Moradi A, Abedi B, Kaboli PJ (2025) Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. J Exp Clin Cancer Res 44:131. https:\/\/doi.org\/10.1186\/s13046-025-03211-6","journal-title":"J Exp Clin Cancer Res"},{"key":"10419_CR53","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","volume":"10","author":"SC Formenti","year":"2009","unstructured":"Formenti SC, Demaria S (2009) Systemic effects of local radiotherapy. Lancet Oncol 10:718\u2013726 2045(09)70082-8","journal-title":"Lancet Oncol"},{"key":"10419_CR54","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S1470-2045(24)00295-5","volume":"25","author":"C Lynch","year":"2024","unstructured":"Lynch C, Pitroda SP, Weichselbaum RR (2024) Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol 25:e352\u2013e362. https:\/\/doi.org\/10.1016\/S1470-2045(24)00295-5","journal-title":"Lancet Oncol"},{"key":"10419_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi HA et al (2022) Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N Engl J Med 386:24\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2109970","journal-title":"N Engl J Med"},{"key":"10419_CR56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nrc.2017.105","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D et al (2017) Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer 17:765. https:\/\/doi.org\/10.1038\/nrc.2017.105","journal-title":"Nat Rev Cancer"},{"key":"10419_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41571-019-0272-7","volume":"17","author":"O Kepp","year":"2020","unstructured":"Kepp O et al (2020) Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies. Nat Rev Clin Oncol 17:49\u201364. https:\/\/doi.org\/10.1038\/s41571-019-0272-7","journal-title":"Nat Rev Clin Oncol"},{"key":"10419_CR58","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1038\/s41467-024-53015-9","volume":"15","author":"P Bergeron","year":"2024","unstructured":"Bergeron P et al (2024) Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade. Nat Commun 15:8845. https:\/\/doi.org\/10.1038\/s41467-024-53015-9","journal-title":"Nat Commun"},{"key":"10419_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R et al (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20\u201337. https:\/\/doi.org\/10.1038\/nrc.2016.108","journal-title":"Nat Rev Cancer"},{"key":"10419_CR60","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18:99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1","journal-title":"Nat Rev Drug Discov"},{"key":"10419_CR61","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1158\/0008-5472.CAN-24-3477","volume":"85","author":"J Yang","year":"2025","unstructured":"Yang J, Chen F, Fu Z et al (2025) Blocking the TCA cycle in cancer cells potentiates CD36\u2009+\u2009T-cell-mediated antitumor immunity by suppressing ER stress-associated THBS2 signaling. Cancer Res 85:2014\u20132026. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3477","journal-title":"Cancer Res"},{"issue":"1","key":"10419_CR62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3892\/ijo.2019.4796","volume":"55","author":"A Maiti","year":"2019","unstructured":"Maiti A, Qi Q, Peng X, Yan L, Takabe K, Hait NC (2019) Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells. Int J Oncol 55(1):116\u2013130. https:\/\/doi.org\/10.3892\/ijo.2019.4796","journal-title":"Int J Oncol"},{"issue":"12","key":"10419_CR63","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/hmg\/ddad022","volume":"32","author":"L Wang","year":"2023","unstructured":"Wang L, Zhang Y, Chen J et al (2023) CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation. Hum Mol Genet 32(12):2062\u20132075. https:\/\/doi.org\/10.1093\/hmg\/ddad022","journal-title":"Hum Mol Genet"},{"key":"10419_CR64","doi-asserted-by":"publisher","first-page":"e34630","DOI":"10.1016\/j.heliyon.2024.e34630","volume":"10","author":"X Sun","year":"2024","unstructured":"Sun X, Wu C, Lin Y et al (2024) Exploring the key genes associated with breast cancer radiotherapy sensitivity based on the stromal-immune score and analysis of the WGCNA and ceRNA network. Heliyon 10:e34630. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34630","journal-title":"Heliyon"},{"key":"10419_CR65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12935-020-01444-z","volume":"20","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020) Circular RNA circ_0020123 promotes non-small cell lung cancer progression by sponging miR-590-5p to regulate THBS2. Cancer Cell Int 20:387. https:\/\/doi.org\/10.1186\/s12935-020-01444-z","journal-title":"Cancer Cell Int"},{"key":"10419_CR66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.placenta.2020.10.023","volume":"103","author":"Y Ye","year":"2021","unstructured":"Ye Y, Li M, Chen L et al (2021) Circ-AK2 is associated with preeclampsia and regulates biological behaviors of trophoblast cells through miR-454-3p\/THBS2. Placenta 103:156\u2013163. https:\/\/doi.org\/10.1016\/j.placenta.2020.10.023","journal-title":"Placenta"},{"key":"10419_CR67","doi-asserted-by":"publisher","first-page":"20540","DOI":"10.18632\/aging.103925","volume":"12","author":"F Zu","year":"2020","unstructured":"Zu F, Han H, Sheng W et al (2020) Identification of a competing endogenous RNA axis related to gastric cancer. Aging 12:20540\u201320560. https:\/\/doi.org\/10.18632\/aging.103925","journal-title":"Aging"},{"key":"10419_CR68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-024-03107-7","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) The RP11-417E7.1\/THBS2 signaling pathway promotes colorectal cancer metastasis by activating the Wnt\/\u03b2-catenin pathway and facilitating exosome-mediated M2 macrophage polarization. J Exp Clin Cancer Res 43:195. https:\/\/doi.org\/10.1186\/s13046-024-03107-7","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-026-10419-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:38:19Z","timestamp":1787031499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-026-10419-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["10419"],"URL":"https:\/\/doi.org\/10.1007\/s10585-026-10419-9","relation":{},"ISSN":["1573-7276"],"issn-type":[{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There has no conflict of interest in this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved this version of the article, and due care has been taken to ensure the integrity of the work. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal. The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"41"}}